X

Therapeutic Advances in Hematology

Therapeutic Advances in Hematology
The Role of Axicabtagene Ciloleucel as a Treatment Option for Patients With Follicular/Marginal Zone Lymphoma

CAR T-cell therapy with axicabtagene ciloleucel continues to make its way in the treatment of B-cell lymphomas.

Therapeutic Advances in Hematology
05/29/2021
The Role of Tazemetostat in Relapsed/Refractory Follicular Lymphoma

Tazemetostat was recently approved for the treatment of patients with relapsed FL after 2 or more prior lines of therapy in the presence of an EZH2 mutation and for those without any other...

Therapeutic Advances in Hematology
05/27/2021
The Role of Acalabrutinib in Adults With Chronic Lymphocytic Leukemia

The two major classes of drugs that have contributed to this dramatic evolution include the Bruton tyrosine kinase inhibitors and BCL2 inhibitors.

Therapeutic Advances in Hematology
02/05/2021
Subscribe to Therapeutic Advances in Hematology

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#6fc969
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#f5ce42
#575662
#a60538
#49cde9
#c20fce
#d95d39
#eb5834